Cargando…

Reflections on 2015

The Editor-in-Chief reflects on recent advances, including CRISPR technology and the expansion of immunotherapy, and highlights trends that will be important in the coming year.

Detalles Bibliográficos
Autor principal: Chabner, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746097/
https://www.ncbi.nlm.nih.gov/pubmed/26786261
http://dx.doi.org/10.1634/theoncologist.2016-0005
_version_ 1782414762022273024
author Chabner, Bruce A.
author_facet Chabner, Bruce A.
author_sort Chabner, Bruce A.
collection PubMed
description The Editor-in-Chief reflects on recent advances, including CRISPR technology and the expansion of immunotherapy, and highlights trends that will be important in the coming year.
format Online
Article
Text
id pubmed-4746097
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AlphaMed Press
record_format MEDLINE/PubMed
spelling pubmed-47460972016-02-17 Reflections on 2015 Chabner, Bruce A. Oncologist Editorial The Editor-in-Chief reflects on recent advances, including CRISPR technology and the expansion of immunotherapy, and highlights trends that will be important in the coming year. AlphaMed Press 2016-02 2016-01-19 /pmc/articles/PMC4746097/ /pubmed/26786261 http://dx.doi.org/10.1634/theoncologist.2016-0005 Text en ©AlphaMed Press
spellingShingle Editorial
Chabner, Bruce A.
Reflections on 2015
title Reflections on 2015
title_full Reflections on 2015
title_fullStr Reflections on 2015
title_full_unstemmed Reflections on 2015
title_short Reflections on 2015
title_sort reflections on 2015
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746097/
https://www.ncbi.nlm.nih.gov/pubmed/26786261
http://dx.doi.org/10.1634/theoncologist.2016-0005
work_keys_str_mv AT chabnerbrucea reflectionson2015